Wells Fargo & Company Hookipa Pharma Inc. Transaction History

Wells Fargo & Company

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$0.61 - $0.83 $4 - $6	8 Added 1.48%	548 $0
Q4 2023 Feb 09, 2024	SELL	$0.42 - $0.86 $30 - $61	-72 Reduced 11.76%	540 $0
Q3 2023 Nov 13, 2023	BUY	$0.58 - $0.91 $184 - $289	318 Added 108.16%	612 $0
Q2 2023 Aug 15, 2023	BUY	$0.71 - $1.97 $8 - $23	12 Added 4.26%	294 $0
Q1 2023 May 12, 2023	SELL	$0.72 - $1.03 $714 - $1,021	-992 Reduced 77.86%	282 $0
Q4 2022 Feb 13, 2023	BUY	$0.73 - $14.6 $263 - $5,270	361 Added 39.54%	1,274 $1,000
Q3 2022 Nov 14, 2022	SELL	$1.27 - $15.0 $25 - $300	-20 Reduced 2.14%	913 $1,000
Q2 2022 Aug 12, 2022	SELL	$1.33 - $2.31 $59,481 - $103,310	-44,723 Reduced 97.96%	933 $1,000
Q1 2022 May 16, 2022	SELL	$1.26 - $2.52 $5,688 - $11,377	-4,515 Reduced 9.0%	45,656 $104,000
Q4 2021 Feb 14, 2022	SELL	$2.33 - $5.94 $199,685 - $509,069	-85,702 Reduced 63.08%	50,171 $117,000
Q3 2021 Nov 15, 2021	BUY	$5.89 - $9.35 $415,928 - $660,259	70,616 Added 108.21%	135,873 $800,000
Q2 2021 Aug 16, 2021	BUY	$9.16 - $19.51 $450,864 - $960,301	49,221 Added 306.94%	65,257 $597,000
Q1 2021 May 13, 2021	SELL	$10.64 - $14.7 $89,620 - $123,818	-8,423 Reduced 34.44%	16,036 $216,000
Q4 2020 Feb 09, 2021	BUY	$9.32 - $13.63 $2,311 - $3,380	248 Added 1.02%	24,459 $271,000
Q3 2020 Nov 05, 2020	SELL	$8.59 - $11.89 $7,043 - $9,749	-820 Reduced 3.28%	24,211 $228,000
Q2 2020 Aug 13, 2020	BUY	$7.23 - $12.1 $131,846 - $220,655	18,236 Added 268.37%	25,031 $291,000
Q1 2020 May 14, 2020	BUY	$5.9 - $13.8 $40,090 - $93,771	6,795 New	6,795 $56,000

677K

Ticker HOOK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 51,654,500
Market Cap $98.7M
Description
HOOKIPA Pharma Inc., a clinical stage biopharmaceutical company, develops immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform. The company's lead infectious disease product candidate is HB-101, which is in a randomized double-blinded Phase II clinical trial in patients awaiting kidney transpl...

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

Stay updated on Wells Fargo & Company with notifications on news.